Release of leukotrienes in patients with bronchial asthma.

[1]  B. Spur,et al.  91 Relative responsiveness to leukotriene E4, methacholine and histamine in normal and asthmatic subjects , 1988 .

[2]  Bernstein Il.  Bronchoalveolar lavage and asthma: sampling the humors speeds up. , 1987 .

[3]  P. O'Byrne,et al.  Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. , 1986, The New England journal of medicine.

[4]  H. Salari.  Immunological and non-immunological release of leukotrienes and histamine by guinea-pig heart. , 1986, Immunology.

[5]  H. Mita,et al.  Allergen induced histamine release and immunoreactive-leukotriene C4 generation from leukocytes in mite sensitive asthmatic patients. , 1986, Prostaglandins.

[6]  A. Wanner,et al.  The effect of an orally active leukotriene D4/E4 antagonist, LY171883, on antigen-induced airway responses in allergic sheep. , 1986, Prostaglandins.

[7]  P. Howarth,et al.  Cellular and biochemical events in the pathogenesis of asthma. , 1986, European journal of respiratory diseases. Supplement.

[8]  P. Howarth,et al.  Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. , 2015, The American review of respiratory disease.

[9]  P. O'Byrne,et al.  Leukotriene B4 induces airway hyperresponsiveness in dogs. , 1985, Journal of applied physiology.

[10]  A. B. Kay,et al.  Airways reversibility after prednisolone therapy in chronic asthma is associated with alterations in leukocyte function. , 1985, The American review of respiratory disease.

[11]  S. Lam,et al.  Effect of bronchial lavage volume on cellular and protein recovery. , 1985, Chest.

[12]  J. Hébert,et al.  Studies on the release of leukotrienes and histamine by human lung parenchymal and bronchial fragments upon immunologic and nonimmunologic stimulation. Effects of nordihydroguaiaretic acid, aspirin, and sodium cromoglycate , 1985, The Journal of experimental medicine.

[13]  T. Goodson,et al.  LY171883, 1-less than 2-hydroxy-3-propyl-4-less than 4-(1H-tetrazol-5-yl) butoxy greater than phenyl greater than ethanone, an orally active leukotriene D4 antagonist. , 1985, The Journal of pharmacology and experimental therapeutics.

[14]  E. Corey,et al.  Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[15]  E. Goetzl,et al.  Selective generation of leukotriene B4 by tracheal epithelial cells from dogs. , 1983, Biochemical and biophysical research communications.

[16]  E. R. Mcfadden,et al.  Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. , 1983, JAMA.

[17]  B. Samuelsson.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. , 1983, Science.

[18]  S. Dahlén,et al.  Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. R. Mcfadden,et al.  Effects of leukotriene D on the airways in asthma. , 1983, The New England journal of medicine.

[20]  K. Frank Austen,et al.  Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human Skin , 1983 .

[21]  E. Corey,et al.  Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa. , 1983, Prostaglandins.

[22]  N. Pawlowski,et al.  Human alveolar macrophages produce leukotriene B4. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. Shelhamer,et al.  The Effects of Arachinoids and Leukotrienes on the Release of Mucus from Human Airways , 1982 .

[24]  W. A. Taylor,et al.  Selective inhibition by betamethasone of allergen-induced release of SRS-A from human lung. , 1982, International archives of allergy and applied immunology.

[25]  E. Corey,et al.  A review of recent contributions on biologically active products of arachidonate conversion. , 1982, International journal of immunopharmacology.

[26]  J. Hill,et al.  Glucocorticoid receptors in normal human eosinophils: comparison with neutrophils. , 1981, The Journal of allergy and clinical immunology.

[27]  M. Dixon,et al.  BRONCHOCONSTRICTION PRODUCED IN MAN BY LEUKOTRIENES C AND D , 1981, The Lancet.

[28]  Bengt Samuelsson,et al.  Leukotrienes are potent constrictors of human bronchi , 1980, Nature.

[29]  G. J. Blackwell,et al.  Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids , 1980, Nature.

[30]  B. Zweiman,et al.  Effects of theophylline, terbutaline, and prednisone on antigen-induced bronchospasm and mediator release. , 1980, The Journal of allergy and clinical immunology.

[31]  M. A. Bray,et al.  Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes , 1980, Nature.

[32]  B. Samuelsson,et al.  Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[33]  B. Simonesson.  Evidence for a Glucocorticoid Receptor in Human Leukocytes , 1976 .